Mucinex Childrens

Description

Mucinex® Children's COLD & FLU is a liquid formulation designed for pediatric use in children aged 6 years and older. Each 4 fluid ounce (118 mL) serving contains 325 mg of acetaminophen, serving as a pain reliever and fever reducer. The formulation also includes 10 mg of dextromethorphan HBr, which acts as a cough suppressant, and 200 mg of guaifenesin, an expectorant that aids in the clearance of mucus. Additionally, it contains 5 mg of phenylephrine HCl, a nasal decongestant that helps relieve nasal congestion. The product is flavored with a very berry taste to enhance palatability.

Uses and Indications

This drug is indicated for the temporary relief of common cold and flu symptoms, including cough, nasal congestion, minor aches and pains, sore throat, headache, stuffy nose, and sinus congestion and pressure. Additionally, it temporarily reduces fever and assists in loosening phlegm (mucus) and thinning bronchial secretions, thereby facilitating the clearance of mucus from the bronchial passageways and making coughs more productive.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in children aged 6 years and older. The dosing must be measured using the dosing cup provided, and it is imperative that this cup is not used with any other products to ensure accurate dosing.

For children aged 6 to under 12 years, the recommended dose is 10 mL, administered every 4 hours as needed while symptoms persist. It is crucial not to exceed 5 doses within a 24-hour period.

For children under 6 years of age, the use of this product is not recommended.

Healthcare professionals should advise caregivers to adhere strictly to these dosing instructions and to consult a physician for any questions or concerns regarding the administration of this product. Additionally, caregivers should be informed of the overdose warning and the importance of not exceeding the recommended dosage.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

• In pediatric patients currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing such treatment. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease. If there is uncertainty about the presence of an MAOI in a child's medication regimen, a healthcare professional should be consulted prior to administration of this product.

Warnings and Precautions

This product contains acetaminophen, which poses a risk of severe liver damage if the child exceeds the maximum daily dosage of 5 doses within a 24-hour period or if it is taken concurrently with other medications containing acetaminophen. Healthcare professionals should be vigilant regarding the potential for severe skin reactions associated with acetaminophen use. Symptoms may include skin reddening, blisters, and rash. Should any of these symptoms manifest, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat that persists for more than 2 days or is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a physician is advised.

General precautions should be observed prior to administration of this product. Healthcare providers should inquire about the child’s medical history, particularly if there is a presence of liver disease, heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as that associated with asthma), or cough accompanied by excessive phlegm. Additionally, it is essential to consult a doctor or pharmacist if the child is currently taking the anticoagulant warfarin. It is critical to adhere strictly to the recommended dosage and not exceed the directed amount.

In the event of an overdose, immediate medical attention is necessary. Contacting a Poison Control Center is also recommended, as timely intervention is crucial, even in the absence of noticeable signs or symptoms.

Healthcare professionals should advise patients to discontinue use and seek medical advice if the child experiences nervousness, dizziness, or sleeplessness. Further, if pain, nasal congestion, or cough worsens or persists beyond 5 days, or if fever intensifies or lasts more than 3 days, medical consultation is warranted. Redness or swelling, the emergence of new symptoms, or a recurrence of cough accompanied by fever, rash, or headache that persists should also prompt immediate medical evaluation, as these may indicate a serious underlying condition.

Side Effects

Severe liver damage may occur in patients who exceed the maximum daily amount of acetaminophen, which is more than 5 doses in 24 hours, or who take this product in conjunction with other medications containing acetaminophen. Patients should be aware that acetaminophen can also lead to severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of a skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

Patients experiencing a severe sore throat that persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, should consult a healthcare professional promptly. This product should not be used in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. Additionally, it is contraindicated in children who are taking a prescription monoamine oxidase inhibitor (MAOI) or for 2 weeks following the cessation of an MAOI.

Before using this product, patients should consult a doctor if the child has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as occurs with asthma), or cough associated with excessive phlegm. Furthermore, consultation with a healthcare provider is advised if the child is taking the anticoagulant warfarin.

While using this product, it is crucial not to exceed the recommended dosage. Patients should discontinue use and seek medical advice if they experience nervousness, dizziness, or sleeplessness; if pain, nasal congestion, or cough worsens or persists beyond 5 days; if fever worsens or lasts more than 3 days; if redness or swelling occurs; if new symptoms arise; or if a cough recurs with fever, rash, or headache lasting longer than expected, as these may indicate a serious condition.

In cases of overdose, which may result in liver damage, immediate medical attention is essential, even if no signs or symptoms are present. Patients should contact a Poison Control Center or seek medical help without delay.

Drug Interactions

Co-administration of this medication with any other drug containing acetaminophen, whether prescription or nonprescription, is contraindicated due to the risk of acetaminophen overdose, which can lead to severe liver damage.

In pediatric patients, the use of this medication is contraindicated in those who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken an MAOI within the past two weeks. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, and Parkinson's disease. The combination may lead to serious adverse effects.

Additionally, it is advisable to consult a healthcare professional, such as a doctor or pharmacist, prior to administering this medication to a child who is concurrently taking the anticoagulant warfarin. Monitoring may be necessary to ensure safe use and to avoid potential interactions that could affect coagulation parameters.

Packaging & NDC

Below are the non-prescription pack sizes of Mucinex Childrens (acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children aged 6 to under 12 years may be administered 10 mL of the medication using the dosing cup provided every 4 hours while symptoms persist, with a maximum of 5 doses in any 24-hour period. For children under 6 years of age, the use of this medication is not recommended.

Healthcare professionals should be aware of the potential for severe liver damage if the maximum daily dosage of 5 doses is exceeded. Additionally, acetaminophen may cause severe skin reactions, including symptoms such as skin reddening, blisters, and rash. If any skin reaction occurs, it is imperative to discontinue use and seek medical assistance immediately.

Prior to administration, it is advisable to consult a physician if the child has a history of liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or persistent or chronic cough, such as that associated with asthma, or cough accompanied by excessive phlegm. Furthermore, consultation with a doctor or pharmacist is recommended if the child is concurrently taking the anticoagulant warfarin.

As a precaution, this medication should be kept out of reach of children.

Geriatric Use

Elderly patients may not have specific recommendations or considerations for the use of Mucinex Children's Cold and Flu, as the prescribing information primarily addresses pediatric use. Consequently, healthcare providers should exercise caution when considering this medication for geriatric patients due to the lack of data on safety and efficacy in this population.

It is advisable for healthcare providers to monitor elderly patients closely if this medication is deemed necessary, taking into account the absence of established guidelines for dosage adjustments or safety profiles in this age group.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider prior to use. While potential risks to the fetus are not specified, caution is advised. There are no specific dosage modifications for pregnant individuals. It is recommended that women of childbearing potential discuss the use of this product with their healthcare provider to ensure informed decision-making regarding potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. It is critical to adhere to the recommended dosing guidelines, as severe liver damage may occur if a child exceeds five doses within a 24-hour period, which is the maximum daily amount. Additionally, the use of this product in conjunction with other medications containing acetaminophen is contraindicated, as this may further increase the risk of liver damage.

Before administering this product, it is advisable to consult a healthcare professional if the child has a history of liver disease. In the event of an overdose, which may result from taking more than the recommended dose, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay. Prompt medical attention is essential, even if no signs or symptoms of overdose are apparent.

Overdosage

In the event of an overdose, defined as the ingestion of more than the recommended dose, there is a significant risk of liver damage. Healthcare professionals should be aware that the severity of the effects may not be immediately apparent, as symptoms can be delayed or absent initially.

It is imperative that individuals who suspect an overdose seek medical assistance promptly. Contacting a Poison Control Center or obtaining medical help without delay is crucial for effective management. Quick medical attention is essential, even in the absence of noticeable signs or symptoms, to mitigate potential complications and ensure appropriate treatment is administered.

Healthcare providers should remain vigilant and prepared to assess and manage any cases of overdose, emphasizing the importance of early intervention in preventing serious health outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience includes the opportunity for healthcare professionals and patients to report side effects through a designated phone number. Reports received may contribute to the ongoing assessment of the safety profile of the product.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is crucial to inform patients not to use this product in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in other medications, they should be encouraged to consult a doctor or pharmacist.

Patients should be cautioned against using this product in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within two weeks of stopping such medication. If there is any doubt regarding the presence of an MAOI in a child's prescription, patients should seek guidance from a healthcare professional.

Patients should be instructed to discontinue use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, they should be advised to stop use and seek medical advice if pain, nasal congestion, or cough worsens or persists for more than five days, or if fever intensifies or lasts longer than three days. Redness or swelling should also prompt a consultation with a healthcare provider, as should the emergence of new symptoms.

If a cough recurs or is accompanied by fever, rash, or a headache that persists, patients should be advised to seek medical attention, as these may indicate a serious condition. It is important to emphasize that patients should not exceed the recommended dosage, and they should be made aware of the overdose warning.

Before using this product, patients should be encouraged to consult a doctor if the child has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or a persistent or chronic cough, such as that associated with asthma. Furthermore, patients should seek medical advice if the child has a cough that produces excessive phlegm (mucus) or if they are taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled room temperature of 20-25°C (68-77°F). Refrigeration is not recommended, as it may compromise the integrity of the product. Proper handling should be observed to maintain the quality and efficacy of the product throughout its shelf life.

Additional Clinical Information

The medication is administered orally, with specific dosing guidelines based on age. For children aged 6 to under 12 years, the recommended dose is 10 mL, taken every 4 hours as needed, not to exceed 5 doses within a 24-hour period. The medication is not recommended for children under 6 years of age.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Mucinex Childrens, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)